Advertisement

Picture EBD Group BioPharm America 2021 Digital BPA2021 650x80
Organisation › Details

NuCana plc (Nasdaq: NCNA)

NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying its ProTide(TM) technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines. NuCana's most advanced ProTide candidates, Acelarin® and NUC-3373, are new chemical entities derived from the nucleoside analogs gemcitabine and 5-fluorouracil, respectively, two widely used chemotherapy agents. Acelarin® is currently being evaluated in clinical studies across several solid tumor indications, including ovarian cancer, biliary cancer and pancreatic cancer. NUC-3373 is currently in a Phase 1 study for the potential treatment of a wide range of advanced solid tumor cancers. *

 

Period Start 2008-01-01 established
  Predecessor NuCana Biomed Ltd.
Products Industry ProTide technology
  Industry 2 Acelarin®
Persons Person Griffith, Hugh S. (NuCana Biomed 2008 CEO + co-founder before Bioenvision)
  Person 2 Kay, Andrew (NuCana 202012– Board Chairman also at Boards of NeRRe Tx + Blueberry Tx former CEO of Algeta)
     
Region Region Edinburgh
  Country United Kingdom (GB)
  Street 3 Lochside Place
  City EH12 9RG Edinburgh
  Tel +44-131-248-3660
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: NuCana plc. (10/2/17). "Press Release: NuCana plc Announces Closing of Initial Public Offering of ADSs and Exercise of Underwriters’ Option to Purchase Additional ADSs". Edinburgh.
     
   
Record changed: 2020-12-27

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for NuCana plc (Nasdaq: NCNA)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC E Hand 650x300px




» top